# Autism Oxytocin Brain Project

> **NCT03033784** · PHASE2 · COMPLETED · sponsor: **Emory University** · enrollment: 51 (actual)

## Conditions studied

- Autism
- Autism Spectrum Disorder

## Interventions

- **DRUG:** 8 International Units (IU) of Oxytocin
- **DRUG:** 24IU of Oxytocin
- **DRUG:** 48IU of Oxytocin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03033784
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-10
- **Primary completion:** 2018-10-03
- **Final completion:** 2018-10-03
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03033784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03033784, "Autism Oxytocin Brain Project". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03033784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*